32
Pharma & HealthcareAvoid
LIC MF Healthcare
LIC · Direct–Growth · rank #13 of 19 by Smart Score
Data updated
Trailing returns
1 Year
7.4%
+12.1% vs index
3 Years
20.1%
+10.7% vs index
5 Years
11.1%
+3.2% vs index
Since launch
17.9%
Year-by-year performance
2024
+43.9%+28.3% vs index
2025
-3.2%-10.9% vs index
2026
+10.2%+16.2% vs index
Why this score
LIC MF Healthcare scores 32/100 — #13 of 19 Pharma & Healthcare fund (Avoid). The main drag is its 5y return (better than only 6% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return11.07% · 6th percentile in category
Fund size99.36 Cr · 3rd percentile in category
Expense ratio1.37% · 13th percentile in category
Volatility16.42 · 28th percentile in category
1Y return7.42% · 32nd percentile in category
3Y return20.11% · 54th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd9.59%
2.Divi's Laboratories Ltd9.07%
3.Neuland Laboratories Ltd6.14%
4.Torrent Pharmaceuticals Ltd6.04%
5.Apollo Hospitals Enterprise Ltd5.75%
25 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.